We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Groupe Crit | EU:CEN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.60 | -0.81% | 73.60 | 73.40 | 74.00 | 74.40 | 73.60 | 74.00 | 1,801 | 17:00:00 |
Hot Features
Premium
RNS Number:2280Q
CeNeS Pharmaceuticals PLC
26 September 2003
CeNeS Pharmaceuticals plc
Interim Results - Tuesday 30 September 2003
CeNeS Pharmaceuticals plc will be announcing its interim results for the six
months ended 30 June 2003 on Tuesday 30 September 2003.
26 September 2003
For further information:
Neil Clark, CeNeS Pharmaceuticals plc - 01223 266466
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORKGGZLMVVGFZM
1 Year Groupe Crit Chart |
1 Month Groupe Crit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
